Arkolith/Insider Trading/MIRM/Form 4

Peetz Christopher

CHIEF EXECUTIVE OFFICER, DirectorMirum Pharmaceuticals, Inc. (MIRM) · full profile →Form 4 · filed Jul 8, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.4M
Net Open-Market Flow
-$2.4M
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 6, 2026Option exercise(M)20K$2.94$59K214K
Jul 6, 2026Sell(S)12K$121.65$1.5M202K
Jul 6, 2026Sell(S)4K$122.34$512K198K
Jul 6, 2026Sell(S)2K$123.74$244K196K
Jul 6, 2026Sell(S)2K$124.79$213K194K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 6, 2026Option exercise(M)20K—$0108K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001614740-26-000011) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML